| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Revenue | $2.61B | +15.3% |
| Cost of Revenue | $618.0M | +6.4% |
| Gross Profit | $1.99B | +18.4% |
| R&D Expense | $642.0M | -2.1% |
| SG&A Expense | $448.0M | -0.4% |
| Operating Income | -$74.0M | +85.7% |
| Pre-tax Income | $46.0M | +113.6% |
| Income Tax | $18.0M | +0.0% |
| Net Income | $28.0M |
| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $409.0M | +22.5% |
| Short-term Investments | $2.11B | +13.2% |
| Accounts Receivable | $621.0M | +11.1% |
| Current Assets | $3.42B | +14.6% |
| Total Assets | $9.44B | +5.0% |
| Current Liabilities | $2.52B | +41.6% |
| Total Liabilities | $3.03B | -2.2% |
| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $750.0M | +46.5% |
| Capital Expenditures | $8.0M | +0.0% |
| Investing Cash Flow | -$314.0M | -171.2% |
| Financing Cash Flow | -$359.0M | +59.3% |
| Free Cash Flow | $742.0M | +47.2% |
| +107.9% |
| EPS (Basic) | $0.16 | +107.4% |
| EPS (Diluted) | $0.06 | +102.8% |
| Stockholders' Equity |
| $6.41B |
| +8.8% |